Probing the behavior of bovine serum albumin upon binding to atenolol: insights from spectroscopic and molecular docking approaches

被引:22
作者
Jiang, Tuo-Ying [1 ]
Zhou, Kai-Li [1 ]
Lou, Yan-Yue [1 ]
Pan, Dong-qi [1 ]
Shi, Jie-Hua [1 ]
机构
[1] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China
关键词
atenolol; bovine serum albumin; interaction; spectroscopy; molecular docking; IN-VITRO; DRUG; ACID; DERIVATIVES;
D O I
10.1080/07391102.2017.1311805
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular interaction of atenolol, a selective (1) receptor antagonist with the major carrier protein, bovine serum albumin (BSA), was investigated under imitated physiological conditions (pH 7.4) by means of fluorescence spectroscopy, UV absorption spectroscopy, Fourier transform infrared spectroscopy (FT-IR), and molecular modeling studies. The steady-state fluorescence spectra manifested that static type, due to formation of the atenolol-BSA complex, was the dominant mechanism for fluorescence quenching. The characteristic information about the binding interaction of atenolol with BSA in terms of binding constant (K-b) were determined by the UV-vis absorption titration, and were found to be in the order of 10(3)M(-1) at different temperatures, indicating the existence of a weak binding in this system. Thermodynamic analysis revealed that the binding process was primarily mediated by van der Waals force and hydrogen bonds due to the negative sign for enthalpy change (H-0), entropy change (S-0). The molecular docking results elucidated that atenolol preferred binding on the site II of BSA according to the findings observed in competitive binding experiments. Moreover, via alterations in synchronous fluorescence, three-dimensional fluorescence and FT-IR spectral properties, it was concluded that atenolol could arouse slight configurational and micro-environmental changes of BSA.
引用
收藏
页码:1095 / 1107
页数:13
相关论文
共 46 条
[1]   PERMEABILITY OF THE BLOOD-BRAIN-BARRIER FOR ATENOLOL STUDIED BY POSITRON EMISSION TOMOGRAPHY [J].
AGON, P ;
GOETHALS, P ;
VANHAVER, D ;
KAUFMAN, JM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (08) :597-600
[2]  
Alam MA, 2009, J HEALTH POPUL NUTR, V27, P20
[3]  
AMERY A, 1977, CLIN PHARMACOL THER, V21, P691
[4]   Physicochemical aspects of the energetics of binding of sulphanilic acid with bovine serum albumin [J].
Banipal, Tarlok S. ;
Kaur, Amandeep ;
Banipal, Parampaul K. .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2017, 170 :214-225
[5]   A SPECTROPHOTOMETRIC INVESTIGATION OF THE INTERACTION OF IODINE WITH AROMATIC HYDROCARBONS [J].
BENESI, HA ;
HILDEBRAND, JH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1949, 71 (08) :2703-2707
[6]   Interaction of Hydralazine with Human Serum Albumin and Effect of β-Cyclodextrin on Binding: Insights from Spectroscopic and Molecular Docking Techniques [J].
Bolattin, Mallavva B. ;
Nandibewoor, Sharanappa T. ;
Joshi, Shrinivas D. ;
Dixit, Sheshagiri R. ;
Chimatadar, Shivamurti A. .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2016, 55 (19) :5454-5464
[7]  
BROWN HC, 1976, CLIN PHARMACOL THER, V20, P524
[8]  
CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
[9]   STRUCTURE OF HUMAN SERUM-ALBUMIN [J].
CARTER, DC ;
HE, XM .
SCIENCE, 1990, 249 (4966) :302-303
[10]   Phenotypic Characterization of the Binding of Tetracycline to Human Serum Albumin [J].
Chi, Zhenxing ;
Liu, Rutao .
BIOMACROMOLECULES, 2011, 12 (01) :203-209